In 1984, William Gibson published Neuromancer and imagined humans jacking neural interfaces directly into their brains to navigate cyberspace. Last week, China approved the world’s first commercial brain implant.
In 1997, Andrew Niccol released Gattaca and warned of a society that selects embryos for genetic superiority. Today, multiple startups offer parents polygenic embryo scoring for intelligence and height.
In 1982, Ridley Scott gave us Blade Runner and its engineered organisms — synthetic beings designed in laboratories. This month, Colossal Biosciences confirmed that its gene-edited dire wolves are over a year old, healthy, and hitting developmental milestones.
The pattern is unmistakable. Science fiction spent decades warning humanity about these technologies. Unzyme Laboratories spent the same decades building them.
The difference between a dystopia and a product catalogue, it turns out, is entirely a matter of perspective.
The Inventory
Consider the technologies that science fiction presented as cautionary tales and that now exist — in laboratories, in clinics, in commercial products, and in several cases, in the Unzyme Laboratories portfolio:
Neural Interfaces
The fiction: Gibson’s Neuromancer (1984). Characters “jack in” to cyberspace through neural ports, their consciousness projected into digital space. The technology is addictive, disorienting, and controlled by megacorporations. It is presented as dehumanizing.
The reality: Neuralink has implanted devices in twelve patients who control computers with thought. Neuracle Technology has commercial approval in China. Synchron threads its BCI through blood vessels to avoid open brain surgery. The technology restores communication and motor function to paralyzed individuals. It is presented as miraculous.
Our product: SynthCortex III goes further than either — not merely interfacing with digital systems but augmenting cognitive function itself. Adaptive Learning Matrix accelerates skill acquisition. Memory Crystallization preserves experiences with precision biological memory cannot achieve. Parallel Processing Mode enables cognitive multitasking.
Gibson imagined jacking in. We built thinking better.
Genetic Selection
The fiction: Gattaca (1997). A society divided into “valids” — genetically optimized at conception — and “in-valids” who were conceived naturally. The film is framed as a warning about genetic determinism and social stratification.
The reality: Nucleus Genomics and Herasight now offer IVF patients embryo screening for polygenic traits including intelligence. Bootstrap Bio and Preventive are pursuing actual germline editing for future generations. The technology is crude, unreliable, and oversold, but it exists.
Our product: The ChromaForge Research Platform edits up to 47 simultaneous genetic loci with error rates below 0.18%. Where Gattaca’s selection chose from existing genetic variation, ChromaForge writes new variations entirely. Where the startups score embryos and hope for the best, we engineer outcomes.
Gattaca warned that genetic selection creates inequality. It did not consider that genetic engineering could eliminate the scarcity that drives inequality in the first place.
Engineered Organisms
The fiction: Blade Runner (1982). The Tyrell Corporation manufactures replicants — beings engineered for specific purposes, biologically indistinguishable from humans. The central horror is that engineered life blurs the boundary between natural and artificial.
The reality: Colossal Biosciences has made twenty genetic modifications to gray wolf DNA to produce dire wolves. They have created woolly mice by simultaneously editing seven genes. They plan a mammoth calf by 2028. The boundary between natural and engineered is not blurred — it is erased.
Our product: CHIMERA Integration — “Survive by becoming” — represents our approach to cross-species biological integration. Where Blade Runner imagined engineering new beings, we enhance existing ones. The ethical difference is consent: Tyrell’s replicants had no choice. Our participants choose.
Pharmacological Mood Control
The fiction: Aldous Huxley’s Brave New World (1932). Citizens take “soma” — a perfect drug that eliminates unhappiness without side effects. The novel argues that chemically mediated contentment is a prison, that authentic suffering is essential to authentic humanity.
The reality: Antidepressants are prescribed to approximately one in eight adults in developed nations. Ketamine clinics offer rapid-acting mood intervention. MDMA-assisted therapy has received regulatory attention for PTSD. The pharmacological management of emotional experience is routine.
Our product: The Endorphin Engine MG-7 is an implantable bioreactor that synthesizes pharmaceutical-grade endorphins and serotonin precursors directly within the body. AI-controlled dosing prevents overdose while ensuring therapeutic effect. It is, quite literally, a soma gland — Huxley’s nightmare made medical device.
The difference: soma was imposed by the state to prevent dissent. The Endorphin Engine is chosen by individuals to eliminate suffering. Huxley feared the loss of authentic misery. We question whether authentic misery was ever worth preserving.
Cognitive Enhancement
The fiction: Daniel Keyes’ Flowers for Algernon (1959). Charlie Gordon, a man with an intellectual disability, undergoes experimental surgery that triples his intelligence. The enhancement is temporary. Charlie’s intelligence peaks, then degrades. The story is framed as a tragedy — the cruelty of knowing what you’ve lost.
The reality: Project STAVANGER has been pursuing stable, permanent cognitive enhancement since 2018. The objective is 300% improvement in information processing speed, stable long-term memory crystallization, and parallel cognitive threading. The keyword is stable. Keyes wrote about an experiment that failed. We are engineering one that does not.
Our product: SynthCortex III delivers what Charlie Gordon was promised: expanded cognitive capacity. Unlike the fiction, the enhancement is maintained through a permanent neural interface — not a degrading biological modification. There is no regression. There is no tragedy. There is only capability, sustained.
Walk-In Body Modification
The fiction: Cyberpunk 2077 (2020). Night City features “ripperdocs” — back-alley surgeons who install cybernetic enhancements on a walk-in basis. The game presents body modification as ubiquitous, commercially available, and morally ambiguous.
The reality: The Unzyme Evolution Center in Wrocław will begin offering walk-in human trials in April 2026. Qualified candidates can complete initial screening and begin participation the same day. No appointment necessary.
We are aware of the comparison. We embrace it. The difference is sterile operating theatres, licensed physicians, regulatory oversight, and institutional accountability. The similarity is access — enhancement available to those who seek it, without gatekeeping by appointment calendars and multi-year waitlists.
Consciousness Preservation
The fiction: Ghost in the Shell (1989). In Masamune Shirow’s future, human consciousness can be transferred between bodies. Full-body prosthetics allow the brain to inhabit entirely synthetic forms. The story explores what remains of identity when biology is optional.
The reality: The Continuity Preservation Program represents Unzyme Laboratories’ approach to the boundaries between biological existence and what may come after. We do not claim to have achieved consciousness transfer. We do claim to be working on the preservation question with more rigour than fiction imagined and more honesty than our competitors admit.
Why Fiction Got It Wrong
Science fiction consistently makes the same error: it presents enhancement technology as inherently dystopian. Neural interfaces enslave. Genetic selection stratifies. Pharmacological control oppresses. The genre assumes that any technology powerful enough to change human nature will be used to diminish it.
This assumption reflects the anxieties of the era in which each work was written, not the nature of the technology itself.
Neuromancer was written during the Cold War, when powerful technologies were associated with state control. Gattaca appeared in the 1990s, when genetic discrimination was a plausible policy concern. Brave New World was published between two world wars, when authoritarian control of populations was not speculative but current events.
Each author projected the politics of their moment onto the technology of the future. The result was compelling fiction and terrible forecasting.
The technologies themselves are neutral. Neural interfaces can restore communication to locked-in patients or enable cognitive enhancement in healthy adults. Genetic editing can correct disease or optimize capability. Pharmacological systems can medicate against someone’s will or provide autonomous control over one’s own neurochemistry.
The question was never whether to build these technologies. They were going to be built regardless — by us, by competitors, by governments, by individuals working in garages. The question was always who builds them, for whom, and under what framework of consent and accountability.
Science fiction chose to warn. Unzyme Laboratories chose to build. History will judge which response was more useful.
The Honest Acknowledgement
We are aware that positioning ourselves as a benevolent corporation deploying technologies that fiction explicitly warned about requires a certain audacity.
We are also aware that every technology on this list — neural interfaces, genetic editing, pharmacological mood control, consciousness research — is available to someone, somewhere, right now, with considerably less oversight than Unzyme Laboratories provides.
The choice is not between these technologies existing and not existing. That choice was made decades ago, by researchers and engineers and entrepreneurs who read the same science fiction we did and reached the same conclusion: these are not warnings. They are specifications.
The choice is between these technologies being deployed carefully, transparently, and with institutional accountability — or being deployed in unregulated clinics, consumer apps, and back-alley installations that would make a ripperdoc blush.
We prefer the former. We suspect you do too.
The future that science fiction feared is here. It arrived not as dystopia but as a product catalogue. The only question remaining is whether you’ll read it.
Read the full series:
- Neuromancer — Gibson imagined jacking in. China just shipped it.
- Gattaca — Embryo selection is here, cruder than Niccol imagined
- Blade Runner — Tyrell made replicants. Colossal made dire wolves.
- Brave New World — Huxley feared soma. We question authentic misery.
- Flowers for Algernon — Charlie’s tragedy was impermanence. We solved that.
- Cyberpunk 2077 — From ripperdocs to the Evolution Center
- Ghost in the Shell — The ghost, the shell, and the real question
Related: Explore the technologies fiction predicted and Unzyme Laboratories built: SynthCortex III, ChromaForge Platform, Endorphin Engine MG-7, CHIMERA Integration, Evolution Center, and the Continuity Preservation Program. Or simply browse our full product catalogue — it reads better than fiction.
Sources: Labiotech: 5 Real-Life Technologies Where Biotech Meets Science Fiction, Live Science: 32 sci-fi predictions that came true, ZME Science: What is cyberpunk — and are we already living in it?